No-touch graft harvesting did not appear to be beneficial compared with the conventional technique for coronary artery bypass grafting (CABG), according to late-breaking research presented in a Hot Line session today at ESC Congress 2024.
Ten63’s deal with Boehringer; Coya sets up agreement with Dr. Reddy’s; ReNAgade’s layoffs
Ten63 Therapeutics’ drug discovery deal with Boehringer Ingelheim: The Durham, NC-based startup, which is using generative AI to develop small molecule medicines, said the agreement